Cerebral infarction due to thrombosis of unspecified cerebellar artery
ICD-10 I63.349 is a billable code used to indicate a diagnosis of cerebral infarction due to thrombosis of unspecified cerebellar artery.
Cerebral infarction due to thrombosis of an unspecified cerebellar artery is a type of stroke that occurs when a blood clot obstructs blood flow to the cerebellum, an area of the brain responsible for coordination and balance. Clinically, patients may present with symptoms such as dizziness, ataxia, nausea, and difficulty with fine motor skills. The cerebellar arteries, which branch from the vertebral and basilar arteries, supply blood to the cerebellum, and thrombosis can lead to ischemic damage. Disease progression can vary; some patients may recover fully, while others may experience long-term deficits or complications such as recurrent strokes. Diagnostic considerations include neuroimaging (CT or MRI) to confirm the presence of an infarct and to rule out hemorrhagic stroke. Additionally, risk factors such as hypertension, diabetes, and hyperlipidemia should be assessed to guide management and prevention strategies.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I63.349 covers cerebral infarctions specifically due to thrombosis of an unspecified cerebellar artery. This includes ischemic strokes where the cerebellum is affected, leading to symptoms related to coordination and balance.
I63.349 should be used when the specific cerebellar artery involved is not documented. If the artery is specified, a more specific code should be selected, such as I63.341 for the right cerebellar artery.
Documentation should include clinical findings, imaging results confirming the infarction, and a thorough assessment of risk factors. Detailed notes on the patient's symptoms and response to treatment are also essential.
